Lausanne, Switzerland

Pietro Scalfaro

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Debiopharm International, S.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pietro Scalfaro. Retrieved from https://idiyas.com/inventor/pietro-scalfaro-wcelxphq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pietro Scalfaro: Innovator in Medicinal Chemistry

Introduction

Pietro Scalfaro is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for myocardial ischaemic events. His innovative approach has led to the creation of a unique medicament that utilizes a cyclic undecapeptide.

Latest Patents

Pietro Scalfaro holds 1 patent for his invention titled "Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events." This patent focuses on the application of a cyclic undecapeptide, characterized by a specific structure, to create a medicament aimed at treating patients during critical myocardial ischaemic events.

Career Highlights

Throughout his career, Scalfaro has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Debiopharm International S.A. and Debiopharm S.A., where he has contributed to various innovative projects in drug development.

Collaborations

Pietro Scalfaro has collaborated with esteemed professionals in his field, including Jean-Maurice Dumont and Grégoire Vuagniaux. These collaborations have further enhanced his research and development efforts, leading to advancements in medicinal applications.

Conclusion

Pietro Scalfaro's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the development of treatments for myocardial ischaemic events highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…